Company
Headquarters: Beijing, China
Employees: 508
CN¥9.72 Billion
CNY as of Jan. 1, 2025
US$1.33 Billion
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Inner Mongolia Furui Medical Science Co., Ltd. operates as a professional medical service platform company. The company provides disease diagnosis, drug treatment, and chronic disease management products in the liver disease field. It also offers health management center and medical care services. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥1.33 B |
| EBITDA | CN¥284.0 M |
| Gross Profit TTM | CN¥862.3 M |
| Profit Margin | 9.83% |
| Operating Margin | 17.86% |
| Quarterly Revenue Growth | 19.40% |
Inner Mongolia Furui Medical Science Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300049 wb_incandescent